Morgan Crucible Co PLC
17 March 2004
The Issuer advises the following replaces Director Shareholdings released today
at 16.36 Number 6517W. The holding for Mr W. Knowlton should be Rights 75,000
and Holding 375,000. All other details remain unchanged full amended text
appears below.
THE MORGAN CRUCIBLE COMPANY PLC
In accordance with the terms of the Rights Issue announced on 19th February
2004, the directors of The Morgan Crucible Company plc took up their Rights to
subscribe for New Shares under the Rights Issue and thereby increased their
interest in the ordinary shares of the Company. The table below details the
number of Rights taken up by each director and their resulting beneficial
holding in the ordinary shares of the Company:
Director Rights Holding
Lars Kylberg 13,018 65,094
Warren Knowlton 75,000 375,000
Nigel Young 11,874 59,374
Sir Clive Whitmore 698 3,491
Sir Alan Cox 23,265 116,325
David Godwin 21,250 106,250
Joseph MacHale 20,000 100,000
Name of contact and telephone number for queries:
Mr D.J. Coker, Company Secretary tel. 01753 837222
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.